Named Patient Programs vs Compassionate Use Programs in the European Union (EU)
What is a Named Patient Program (NPP) in the EU? A Named Patient Program (NPP) is a regulatory pathway that allows a patient and clinician to request access to an…
Bulgarian Epilepsy Patients Struggle to Access Newer Medicines Amid Shortages
Epilepsy patients in Bulgaria are reporting new challenges when it comes to accessing their required medications. These challenges include a lack of advanced therapies, which are commonly used across the…
Ikris Pharma Network Bulgaria: A Trusted Provider of Named Patient Programs
In the complex landscape of global healthcare, access to essential medicines is a critical issue, especially for patients who require treatments that are not yet approved in their home countries.…
Named Patient Services: Importing Unlicensed Medicines for Patient Care
The process of importing unlicensed medicines through Named Patient Services involves several critical steps, each requiring meticulous attention to detail and adherence to regulatory standards...
The Impact of Named Patient Medicine Programs on Global Health: A Deep Dive
In the evolving landscape of global healthcare, access to critical medicines remains a significant challenge, particularly for patients with rare or life-threatening conditions. Named Patient Medicine Programs (NPPs) have emerged…
